In those patients, addressing the underlying metabolic dysfunction first, through dietary intervention, GLP-1 therapy if indicated, or NAD+ support for cellular energy metabolism, is the clinical priority
Recently the FDA banned the prescribing of many peptides
Understanding what evidence actually exists versus what marketing claims suggest proves essential
This is what most of our initial consultations look like: Ive done the research, I know I want to start a weight loss injection, but I cannot figure out whether Mounjaro or Wegovy is the one for me. This is a very valid concern for someone starting their transformation journey
While Semaglutide revolutionized the field as a mono-agonist and Tirzepatide pushed boundaries as a dual agonist, Retatrutides inclusion of the Glucagon receptor agonist creates a synergistic effect that not only suppresses appetite but actively drives energy expenditure